chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Biopsy skin abnormal, Erythema elevatum diutinum, Leukocytoclastic vasculitis, Rash
Clinical narrative: This case was received on 26/June/2009 via QScan search, under reference # 345074. A 19-year-old patient received the following vaccination on 01 July 2008: ACAM2000, lot number not reported. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Twenty-five days post ACAM2000 vaccination the patient was hospitalized with extensor surfaces rash on elbows, knuckles and knees. The result of a skin biopsy on 26 May 2009 was leukocytoclastic vasculitis consistent with erythema elevatum diutinum. The final diagnosis was hypersensitivity vasculitis post vaccination developed leukocytoclastic vasculitis, erythema elevatum diutinum. There is a discrepancy with the data for the skin biopsy in the event data field versus the free text narrative field in the data reported. The patient's outcome was reported as recovered. No other information was provided. List of documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Idiopathic thrombocytopenic purpura, Lymphadenopathy, Petechiae, Platelet count decreased, Thrombocytopenia
Clinical narrative: This case was received on 26/June/2009 via a QScan search on the VAERS database, under reference # 345190.  A 20-year-old patient received the following vaccinations on 16 April 2009:  smallpox VACCINIA (ACAM2000, lot number VV04003A) and TYPHIM VI, (lot number B0347).  Seven days post-vaccination the patient was hospitalized for severe thrombocytopenia and idiopathic thrombocytopenia Purpura in association with the receipt of vaccines.  The symptoms experienced by the subject were petechiae and axillary lymphadenopathy.  Platelet counts tested on 26 April 2009 were 1,000 (units not provided); on 27 April 2009 were 16,000 and on 28 April 2009 were 34,000.  No additional information was provided.  List of documents held by sender:  None.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Furuncle, Hypokinesia, Injection site erythema, Injection site swelling, Insomnia
Clinical narrative: This case was received on 13 August 2009 via a QScan search on database, under reference number 345405. A 32 year old male patient received ACAM2000 (lot number not reported). Ten days later the patient developed a "golf ball size node in the armpit of the injected limb. The patient reported difficulty sleeping and painful movement as a result. The patient also reported 2 boils on his face, one around the left eye and one on the left side of the jaw. The injection site was extremely red and swollen. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. List of documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Nodule, Pain
Clinical narrative: This case was received on 13 August 2009 via a QScan search on database, under reference number 345405. A 32 year old male patient received ACAM2000 (lot number not reported). Ten days later the patient developed a "golf ball size node in the armpit of the injected limb. The patient reported difficulty sleeping and painful movement as a result. The patient also reported 2 boils on his face, one around the left eye and one on the left side of the jaw. The injection site was extremely red and swollen. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. List of documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Furuncle, Injection site erythema, Injection site swelling, Insomnia, Lymphadenopathy
Clinical narrative: This case was received on 13 August 2009 via a QScan search on database, under reference number 345405. A 32 year old male patient received ACAM2000 (lot number not reported). Ten days later the patient developed a "golf ball size node in the armpit of the injected limb. The patient reported difficulty sleeping and painful movement as a result. The patient also reported 2 boils on his face, one around the left eye and one on the left side of the jaw. The injection site was extremely red and swollen. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. List of documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Pain
Clinical narrative: This case was received on 13 August 2009 via a QScan search on database, under reference number 345405. A 32 year old male patient received ACAM2000 (lot number not reported). Ten days later the patient developed a "golf ball size node in the armpit of the injected limb. The patient reported difficulty sleeping and painful movement as a result. The patient also reported 2 boils on his face, one around the left eye and one on the left side of the jaw. The injection site was extremely red and swollen. No additional information was provided. Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patients vaccination. List of documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema, Induration, Pain
Clinical narrative: Induration, pain, erythema, injection site erythema. This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 345411. A 20 year old male patient received the following vaccines on 18 April 2009: smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04-003A); typhoid vaccine (Typhim Vi, lot number A0522); and anthrax vaccine (Biothrax, Emergent Biosolutions, lot number FAV149). The site of vaccination was not reported for any of the vaccines. On the day of vaccination, the left deltoid site of vaccination was reported to be erythematous. The patient also had a pea-sized, painful, hardened red area located mid clavicular on the left side. The patient was treated with Keflex (500mg 4 times per day for 10 days). The patient recovered. 1) Vaccine type: ACAM2000 (SMALLPOX VACCINE). Route site: Percutaneous, Not reported. 2) Vaccine type: TYPHIM Vi (TYPHOID VACCINE). 3) ANTHRAX. Route site: INtramuscular, Not reported.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema, Induration, Injection site erythema, Pain
Clinical narrative: Induration, pain, erythema, injection site erythema. This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 345411. A 20 year old male patient received the following vaccines on 18 April 2009: smallpox (vaccinia) vaccine, live (ACAM2000, lot number VV04-003A); typhoid vaccine (Typhim Vi, lot number A0522); and anthrax vaccine (Biothrax, Emergent Biosolutions, lot number FAV149). The site of vaccination was not reported for any of the vaccines. On the day of vaccination, the left deltoid site of vaccination was reported to be erythematous. The patient also had a pea-sized, painful, hardened red area located mid clavicular on the left side. The patient was treated with Keflex (500mg 4 times per day for 10 days). The patient recovered. 1) Vaccine type: ACAM2000 (SMALLPOX VACCINE). Route site: Percutaneous, Not reported. 2) Vaccine type: TYPHIM Vi (TYPHOID VACCINE). 3) ANTHRAX. Route site: INtramuscular, Not reported.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Abdominal pain upper, Cellulitis, Injection site erythema, Injection site pain
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 345416. A 23 year old male patient received the following vaccines on 18 April 2009: ACAM2000 (lot number VV04-003A); TYPHIM VI (lot number AO0522); and BIOTHRAX (lot number FAV149). Twelve days after vaccination, the patient developed redness and pain at the injection site, which was increasing in size. The patient also experienced stomach cramping with meals. The patient was diagnosed with cellulitis and treated with KEFLEX EQ (250 mg, 4 times daily for 10 days). The patient recovered. NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only Licensed smallpox vaccine at the time of the patient's vaccination and the lot number has been verified as an ACAM2000 lot number. The manufacturer for TYPHIM VI was also reported as unknown. However, AO0522 is a valid lot number for TYPHIM VI. List of documents held by sender: none.
Age: 23.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Folliculitis
Clinical narrative: This case was received on 13 August 2009 via Qscan search on the database, under reverence number 345892. A 23 year old male patient received the following vaccines on April 2009; ACAM2000 (lot number VV04-003A); Typhim Vi (lot number B0424-2); and Biothrax (Emergent Biosolutions, lot number FAV164). One day after vaccination, the patient developed peri-umbilical folliculitis. No treatment was required. No additional information was provided.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Genital lesion, Herpes simplex serology negative, Polymerase chain reaction, Pyrexia, Secondary transmission
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the database under reference number 346255. The patient is a 26 year old female who was diagnosed with secondary transmission of vaccinia. The patient had contact with her boyfriend who received smallpox (vaccinia) vaccine live (ACAM2000, lot number VV04-003A) on 16 April 2009. The patient noted painful, perineal lesions on 30 April 2009. She also developded a lesion on her right thumb and lesions on her upper left thigh. She had a fever (maximum temperature 101 degrees fahrenheit) without significant systemic symptoms. The report also includes left neck soreness, bilateral inguinal adenopathy, fatigue, and malaise.  The patient was evaluated in an Emergency Room on 05 May 2009 and treated initially for herpes with Valtrex and pain medication. HSV cultures were negative. Vaccinia PCR and cultures send to a state lab. No results were reported. The patient was counseled on precautions to avoid the spread of vaccinia.  No additional information was provided.  Note: Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Skin lesion
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the database under reference number 346255. The patient is a 26 year old female who was diagnosed with secondary transmission of vaccinia. The patient had contact with her boyfriend who received smallpox (vaccinia) vaccine live (ACAM2000, lot number VV04-003A) on 16 April 2009. The patient noted painful, perineal lesions on 30 April 2009. She also developded a lesion on her right thumb and lesions on her upper left thigh. She had a fever (maximum temperature 101 degrees fahrenheit) without significant systemic symptoms. The report also includes left neck soreness, bilateral inguinal adenopathy, fatigue, and malaise.  The patient was evaluated in an Emergency Room on 05 May 2009 and treated initially for herpes with Valtrex and pain medication. HSV cultures were negative. Vaccinia PCR and cultures send to a state lab. No results were reported. The patient was counseled on precautions to avoid the spread of vaccinia.  No additional information was provided.  Note: Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Culture, Fatigue, Herpes simplex serology negative, Lymphadenopathy, Malaise
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the database under reference number 346255. The patient is a 26 year old female who was diagnosed with secondary transmission of vaccinia. The patient had contact with her boyfriend who received smallpox (vaccinia) vaccine live (ACAM2000, lot number VV04-003A) on 16 April 2009. The patient noted painful, perineal lesions on 30 April 2009. She also developded a lesion on her right thumb and lesions on her upper left thigh. She had a fever (maximum temperature 101 degrees fahrenheit) without significant systemic symptoms. The report also includes left neck soreness, bilateral inguinal adenopathy, fatigue, and malaise.  The patient was evaluated in an Emergency Room on 05 May 2009 and treated initially for herpes with Valtrex and pain medication. HSV cultures were negative. Vaccinia PCR and cultures send to a state lab. No results were reported. The patient was counseled on precautions to avoid the spread of vaccinia.  No additional information was provided.  Note: Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Neck pain, Perineal pain, Polymerase chain reaction, Pyrexia, Secondary transmission
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the database under reference number 346255. The patient is a 26 year old female who was diagnosed with secondary transmission of vaccinia. The patient had contact with her boyfriend who received smallpox (vaccinia) vaccine live (ACAM2000, lot number VV04-003A) on 16 April 2009. The patient noted painful, perineal lesions on 30 April 2009. She also developded a lesion on her right thumb and lesions on her upper left thigh. She had a fever (maximum temperature 101 degrees fahrenheit) without significant systemic symptoms. The report also includes left neck soreness, bilateral inguinal adenopathy, fatigue, and malaise.  The patient was evaluated in an Emergency Room on 05 May 2009 and treated initially for herpes with Valtrex and pain medication. HSV cultures were negative. Vaccinia PCR and cultures send to a state lab. No results were reported. The patient was counseled on precautions to avoid the spread of vaccinia.  No additional information was provided.  Note: Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 26.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Skin lesion, Vaccinia virus infection
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the database under reference number 346255. The patient is a 26 year old female who was diagnosed with secondary transmission of vaccinia. The patient had contact with her boyfriend who received smallpox (vaccinia) vaccine live (ACAM2000, lot number VV04-003A) on 16 April 2009. The patient noted painful, perineal lesions on 30 April 2009. She also developded a lesion on her right thumb and lesions on her upper left thigh. She had a fever (maximum temperature 101 degrees fahrenheit) without significant systemic symptoms. The report also includes left neck soreness, bilateral inguinal adenopathy, fatigue, and malaise.  The patient was evaluated in an Emergency Room on 05 May 2009 and treated initially for herpes with Valtrex and pain medication. HSV cultures were negative. Vaccinia PCR and cultures send to a state lab. No results were reported. The patient was counseled on precautions to avoid the spread of vaccinia.  No additional information was provided.  Note: Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Myopericarditis
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346318. A 21 year old male patient smallpox vaccine (manufacturer unknown, lot number not reported) and anthrax vaccine (manufacturer unknown, lot number not reported) on 22 April 2009. Ten days post vaccination the patient experienced chest pain, shortness of breath, fatigue and chills. The patient was hospitalized on 04 May 2009 to 05 May 2009. Laboratory and diagnostic evaluation during hospitalization included increased Troponin of 1.1 mg/dL, increased red blood cell sedimentation rate of 39 (units not provided) and an abnormal electrocardiogram significant for P-R depression diffuse. The final diagnosis was vaccinia associated myopericarditis. The outcome was reported as recovered. No additional information was provided.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Chest pain, Chills, Dyspnoea, Electrocardiogram abnormal, Fatigue
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346318. A 21 year old male patient smallpox vaccine (manufacturer unknown, lot number not reported) and anthrax vaccine (manufacturer unknown, lot number not reported) on 22 April 2009. Ten days post vaccination the patient experienced chest pain, shortness of breath, fatigue and chills. The patient was hospitalized on 04 May 2009 to 05 May 2009. Laboratory and diagnostic evaluation during hospitalization included increased Troponin of 1.1 mg/dL, increased red blood cell sedimentation rate of 39 (units not provided) and an abnormal electrocardiogram significant for P-R depression diffuse. The final diagnosis was vaccinia associated myopericarditis. The outcome was reported as recovered. No additional information was provided.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Myopericarditis, Red blood cell sedimentation rate increased, Troponin increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346318. A 21 year old male patient smallpox vaccine (manufacturer unknown, lot number not reported) and anthrax vaccine (manufacturer unknown, lot number not reported) on 22 April 2009. Ten days post vaccination the patient experienced chest pain, shortness of breath, fatigue and chills. The patient was hospitalized on 04 May 2009 to 05 May 2009. Laboratory and diagnostic evaluation during hospitalization included increased Troponin of 1.1 mg/dL, increased red blood cell sedimentation rate of 39 (units not provided) and an abnormal electrocardiogram significant for P-R depression diffuse. The final diagnosis was vaccinia associated myopericarditis. The outcome was reported as recovered. No additional information was provided.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Chest X-ray normal, Chest pain, Dyspnoea
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Myopericarditis, Tachycardia, Troponin increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Pericardial disease, Troponin I
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB, Blood creatine phosphokinase increased, Blood glucose increased, Blood sodium increased, C-reactive protein increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Chest pain, Dyspnoea, Echocardiogram abnormal, Electrocardiogram abnormal, Hyperventilation
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Lymphocyte percentage decreased, Monocyte count normal, Myopericarditis, Neutrophil count increased, Neutrophil percentage increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Red blood cell sedimentation rate increased, Tachycardia, Troponin increased, White blood cell count increased, X-ray normal
Clinical narrative: This case was received on 13 August 2009 via a QScan search, under reference number 346319. A 19 year old male patient received ACAM2000, Sanofi Pasteur Biologics Co., lot number VV040034 and anthrax vaccine (manufacturer unknown, lot number not reported) on 11 January 2009. Eleven days post vaccination the patient awoke with chest pain and shortness of breath and was tachycardic and short of breath while climbing stairs later that day. He was evaluated that day and sent to a local Emergency Room with the diagnosis of myopericarditis. He was hospitalized overnight and discharged on Endocin. Hospital records obtained reported the final diagnosis as acute myopericarditis post vaccination. It was reported that the patient's chest pain was intermittent, described a dull ache worse with deep breathing and lying flat. The patient's reported laboratory and diagnostic test results from 22 January 2009 were: creatinine phosphokinase: 426; creatinine phosphokinase - MB: 21; troponin: 8.6; white blood cell count: 12.4 thous/UL; neutrophils: 72%; lymphocytes: 16%; absolute neutrophils: 8.9 thous/dL and absolute monocytes: 1; C-Reactive protein increased, blood sodium increased; red blood cell sedimentation rate increased; blood glucose increased. Other findings that were reported included mitral and tricuspid valve incompetence and right bundle branch block. It was also reported that the patient had normal coronary arteries, normal left ventricular systolic function and a normal chest x-ray. The outcome of the patient was reported as recovered. No additional information was provided. List of documents held by sender: None.
Age: 5.0
Sex: F
Vaccine: HPVX, MEA, SMALL, HPVX, MEA, SMALL
Symptoms: Injection site rash, Injection site swelling, Rash
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346326.  A five year old female patient reportedly received the following vaccines on 01 May 2009: smallpox VACCINIA (ACAM2000, lot number not reported); HPV vaccine (manufacturer and lot number not reported); and measles vaccine (manufacturer and lot number not reported).  One day after vaccination the patient developed a rash at the injection site.  Two days later, there was rash and swelling at the injection site approximately 2" X 2" in size.  By day 4, the rash had resolved.  On day 11, another rash appeared at the injection site.  On day 13, the rash had spread to be approximately 4" X 4" in size and red dots had appeared over the entire body.  No additional information was provided.  Note:  Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  List of documents held by sender:  None.
Age: 5.0
Sex: F
Vaccine: HPVX, MEA, SMALL, HPVX, MEA, SMALL
Symptoms: Erythema, Injection site rash, Injection site swelling, Rash generalised
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346326.  A five year old female patient reportedly received the following vaccines on 01 May 2009: smallpox VACCINIA (ACAM2000, lot number not reported); HPV vaccine (manufacturer and lot number not reported); and measles vaccine (manufacturer and lot number not reported).  One day after vaccination the patient developed a rash at the injection site.  Two days later, there was rash and swelling at the injection site approximately 2" X 2" in size.  By day 4, the rash had resolved.  On day 11, another rash appeared at the injection site.  On day 13, the rash had spread to be approximately 4" X 4" in size and red dots had appeared over the entire body.  No additional information was provided.  Note:  Although the manufacturer was reported as unknown in the case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination.  List of documents held by sender:  None.
Age: 40.0
Sex: M
Vaccine: HEP, MNQ, SMALL, HEP, MNQ, SMALL
Symptoms: Chest pain, Electrocardiogram normal, Troponin I
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346331.  A 40 year old male patient received the following vaccines on 06 January 2009:  VACCINIA (ACAM2000, lot number unknown); MENACTRA, (lot number U2616AA; and RECOMBIVAX HB, (Merck, lot number 0398X).  Twenty one days after vaccination the patient reported chest pain over the left breast.  The patient was hospitalized (dates of admission and discharge not provided).  Medical records from 27 January 2009 through 5 February 2009 include final diagnosis of atypical chest pain, hypertension (systemic) and obesity.  Troponin I (performed 27 January 2009) and electrocardiogram (performed 26 January 2009) were reported as normal.  Additional laboratory results included:  cardiac-creatine kinase, 248 (H); creatine kinase MB/creatine kinase total, 3 (L); total cholesterol/HDL ratio, increased; hemoglobin, increased; alanine aminotransferase, increased; blood chloride, decreased; and blood triglycerides, increased.  No additional information was provided.  Note:  There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender:  none.
Age: 40.0
Sex: M
Vaccine: HEP, MNQ, SMALL, HEP, MNQ, SMALL
Symptoms: Alanine aminotransferase increased, Blood chloride decreased, Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Blood triglycerides increased
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346331.  A 40 year old male patient received the following vaccines on 06 January 2009:  VACCINIA (ACAM2000, lot number unknown); MENACTRA, (lot number U2616AA; and RECOMBIVAX HB, (Merck, lot number 0398X).  Twenty one days after vaccination the patient reported chest pain over the left breast.  The patient was hospitalized (dates of admission and discharge not provided).  Medical records from 27 January 2009 through 5 February 2009 include final diagnosis of atypical chest pain, hypertension (systemic) and obesity.  Troponin I (performed 27 January 2009) and electrocardiogram (performed 26 January 2009) were reported as normal.  Additional laboratory results included:  cardiac-creatine kinase, 248 (H); creatine kinase MB/creatine kinase total, 3 (L); total cholesterol/HDL ratio, increased; hemoglobin, increased; alanine aminotransferase, increased; blood chloride, decreased; and blood triglycerides, increased.  No additional information was provided.  Note:  There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender:  none.
Age: 40.0
Sex: M
Vaccine: HEP, MNQ, SMALL, HEP, MNQ, SMALL
Symptoms: Chest pain, Electrocardiogram normal, Haemoglobin increased, Hypertension, Obesity
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346331.  A 40 year old male patient received the following vaccines on 06 January 2009:  VACCINIA (ACAM2000, lot number unknown); MENACTRA, (lot number U2616AA; and RECOMBIVAX HB, (Merck, lot number 0398X).  Twenty one days after vaccination the patient reported chest pain over the left breast.  The patient was hospitalized (dates of admission and discharge not provided).  Medical records from 27 January 2009 through 5 February 2009 include final diagnosis of atypical chest pain, hypertension (systemic) and obesity.  Troponin I (performed 27 January 2009) and electrocardiogram (performed 26 January 2009) were reported as normal.  Additional laboratory results included:  cardiac-creatine kinase, 248 (H); creatine kinase MB/creatine kinase total, 3 (L); total cholesterol/HDL ratio, increased; hemoglobin, increased; alanine aminotransferase, increased; blood chloride, decreased; and blood triglycerides, increased.  No additional information was provided.  Note:  There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender:  none.
Age: 40.0
Sex: M
Vaccine: HEP, MNQ, SMALL, HEP, MNQ, SMALL
Symptoms: Total cholesterol/HDL ratio increased, Troponin I
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346331.  A 40 year old male patient received the following vaccines on 06 January 2009:  VACCINIA (ACAM2000, lot number unknown); MENACTRA, (lot number U2616AA; and RECOMBIVAX HB, (Merck, lot number 0398X).  Twenty one days after vaccination the patient reported chest pain over the left breast.  The patient was hospitalized (dates of admission and discharge not provided).  Medical records from 27 January 2009 through 5 February 2009 include final diagnosis of atypical chest pain, hypertension (systemic) and obesity.  Troponin I (performed 27 January 2009) and electrocardiogram (performed 26 January 2009) were reported as normal.  Additional laboratory results included:  cardiac-creatine kinase, 248 (H); creatine kinase MB/creatine kinase total, 3 (L); total cholesterol/HDL ratio, increased; hemoglobin, increased; alanine aminotransferase, increased; blood chloride, decreased; and blood triglycerides, increased.  No additional information was provided.  Note:  There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study.  List of documents held by sender:  none.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Arthralgia, Erythema, Fatigue, Injection site pain, Lymphadenopathy
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346390. A 27 year old female patient received smallpox (vaccina) vaccine, live (ACAM2000, lot number VV04-003A) on 20 February 2009. On 27 February 2009 (reported as Day 8), the patient developed joint and muscle pain, pain fatigue and lymph node swelling. On Day 9, the symptoms became severe, and the site painful. The patient was evaluated by a physician on Day 12. On Day 16, the patient had a rash described as raised red itchy bumps on the neck and knees. She was evaluated by a physician on Day 18. Medical records received for dates of service from 9 March 2009 through 19 March 2009 include the following assessment: allergic reaction to smallpox vaccination. The records note that the patient presented with myalgias, "macupapular" itchy rash on arms, legs, stomach, and neck and drainage and bleeding from vaccine site. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency had been calculated using the event date. No additional information was provided. List of documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Myalgia, Pruritus, Urticaria
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346390. A 27 year old female patient received smallpox (vaccina) vaccine, live (ACAM2000, lot number VV04-003A) on 20 February 2009. On 27 February 2009 (reported as Day 8), the patient developed joint and muscle pain, pain fatigue and lymph node swelling. On Day 9, the symptoms became severe, and the site painful. The patient was evaluated by a physician on Day 12. On Day 16, the patient had a rash described as raised red itchy bumps on the neck and knees. She was evaluated by a physician on Day 18. Medical records received for dates of service from 9 March 2009 through 19 March 2009 include the following assessment: allergic reaction to smallpox vaccination. The records note that the patient presented with myalgias, "macupapular" itchy rash on arms, legs, stomach, and neck and drainage and bleeding from vaccine site. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency had been calculated using the event date. No additional information was provided. List of documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Allergy to vaccine, Arthralgia, Fatigue, Injection site discharge, Injection site haemorrhage
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346390. A 27 year old female patient received smallpox (vaccina) vaccine, live (ACAM2000, lot number VV04-003A) on 20 February 2009. On 27 February 2009 (reported as Day 8), the patient developed joint and muscle pain, pain fatigue and lymph node swelling. On Day 9, the symptoms became severe, and the site painful. The patient was evaluated by a physician on Day 12. On Day 16, the patient had a rash described as raised red itchy bumps on the neck and knees. She was evaluated by a physician on Day 18. Medical records received for dates of service from 9 March 2009 through 19 March 2009 include the following assessment: allergic reaction to smallpox vaccination. The records note that the patient presented with myalgias, "macupapular" itchy rash on arms, legs, stomach, and neck and drainage and bleeding from vaccine site. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency had been calculated using the event date. No additional information was provided. List of documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Injection site pain, Lymphadenopathy, Myalgia, Rash erythematous, Rash maculo-papular
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346390. A 27 year old female patient received smallpox (vaccina) vaccine, live (ACAM2000, lot number VV04-003A) on 20 February 2009. On 27 February 2009 (reported as Day 8), the patient developed joint and muscle pain, pain fatigue and lymph node swelling. On Day 9, the symptoms became severe, and the site painful. The patient was evaluated by a physician on Day 12. On Day 16, the patient had a rash described as raised red itchy bumps on the neck and knees. She was evaluated by a physician on Day 18. Medical records received for dates of service from 9 March 2009 through 19 March 2009 include the following assessment: allergic reaction to smallpox vaccination. The records note that the patient presented with myalgias, "macupapular" itchy rash on arms, legs, stomach, and neck and drainage and bleeding from vaccine site. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency had been calculated using the event date. No additional information was provided. List of documents held by sender: None.
Age: 27.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash pruritic
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference number 346390. A 27 year old female patient received smallpox (vaccina) vaccine, live (ACAM2000, lot number VV04-003A) on 20 February 2009. On 27 February 2009 (reported as Day 8), the patient developed joint and muscle pain, pain fatigue and lymph node swelling. On Day 9, the symptoms became severe, and the site painful. The patient was evaluated by a physician on Day 12. On Day 16, the patient had a rash described as raised red itchy bumps on the neck and knees. She was evaluated by a physician on Day 18. Medical records received for dates of service from 9 March 2009 through 19 March 2009 include the following assessment: allergic reaction to smallpox vaccination. The records note that the patient presented with myalgias, "macupapular" itchy rash on arms, legs, stomach, and neck and drainage and bleeding from vaccine site. Note: There may be a discrepancy between the event date field and the onset date information in the free text narrative field in the data reported. Latency had been calculated using the event date. No additional information was provided. List of documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL, TYP, SMALL, TYP
Symptoms: Chest pain, Electrocardiogram abnormal, Troponin I
Clinical narrative: This case was received on 13 August 2009 via a QScan search on the VAERS database, under reference # 346405. A 38 year old male patient received ACAM2000 (lot number VV04-003A) and TYPHIM VI (lot number B0242) on 13 January 2009. Twenty one days after vaccination the patient complained of substernal chest pain, palpitations at rest, jaw pain, chest tightness and feeling anxious. The patient was hospitalized (dates of admission and discharge not provided). Medical records from 21 January 2009 through 3 February 2009 report that the palpitations had resolved. Troponin I (performed 15 January 2009) was normal. An electrocardiogram (performed 15 January 2009) was abnormal. The records also include a normal electrocardiogram however a date was not provided for this test. The following are additional laboratory results noted from the record: chest x-ray, normal; WBC, increased; creatine phosphokinase, increased; aPTT, shortened; neutrophil count, increased; blood glucose, increased; and single photon emission computerised tomogram, abnormal. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. List of documents held by sender: None.